Bell Investment Advisors, Inc Roivant Sciences Ltd. Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 912 shares of ROIV stock, worth $9,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
912
Previous 747
22.09%
Holding current value
$9,594
Previous $8,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
329Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$692 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$653 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$503 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$372 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.41B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...